Norwood Abbey to acquire Virosome Biologicals Netherlands based company for E25,000,000 to develop vew vaccines uncluding injectable and pandemic influenza vaccines.
NAL Price at posting:
0.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
